Podcast: Has Russia’s COVID Vaccine Gotten Lost In Politics?
A healthcare worker preparing a dose of the Sputnik V COVID-19 vaccine before administrating it to her colleague at the Montenegrian Hospital in Podgorica. Photo: Filip Filipovic/Getty Images
Sign Up for More From Carnegie.ru
If you enjoyed reading this, subscribe for more!
This episode looks at the domestic and international reception of Russia’s Sputnik V vaccine.
Is Russia’s Sputnik V coronavirus vaccine as successful as the Kremlin claims? Are political considerations really preventing it from getting approval in Western countries? Why is the vaccination rate so low in Russia, and why didn’t Putin get vaccinated sooner? Podcast host Alex Gabuev is joined by Henry Foy, Moscow bureau chief of the Financial Times; and Polina Ivanova, a special correspondent for Reuters in Moscow.
Carnegie does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.
The Global Think Tank
Sign up for Carnegie email
Enter your email address to receive the latest Carnegie analysis in your inbox!
Popular Articles :
23.09Why the Kremlin Isn’t Celebrating the Duma Election Results
17.09Have Moscow and Minsk Really Made a Breakthrough on Integration?
17.09How the Duma Elections Could Decide United Russia’s Fate
10.09How Russia Could Recalibrate Its Relationship With Ukraine
25/9 Sivtsev Vrazhek Pereulok
Phone: +7 495 935-8904
Fax: +7 495 935-8906
In an increasingly crowded, chaotic, and contested world and marketplace of ideas, the Carnegie Moscow Center offers decisionmakers global, independent, and strategic insight and innovative ideas that advance international peace.
© 2021 All Rights Reserved